Mednax Inc (MD) Shares Slide -9.22%

Mednax Inc (MD) : During the past 4 weeks, traders have been relatively bearish on Mednax Inc (MD), hence the stock is down -8.42% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -9.16% relative to the S&P 500. The 4-week change in the price of the stock is -5.34% and the stock has fallen -9.22% in the past 1 week.

The stock has recorded a 20-day Moving Average of 7.65% and the 50-Day Moving Average is 3.28%. MEDNAX, Inc. has dropped 3.34% during the last 3-month period . Year-to-Date the stock performance stands at -3.84%.


Mednax Inc (NYSE:MD): On Fridays trading session , Opening price of the stock was $69.31 with an intraday high of $69.84. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $68.18. However, the stock managed to close at $68.91, a loss of 1.46% for the day. On the previous day, the stock had closed at $69.93. The total traded volume of the day was 1,143,717 shares.

MEDNAX, Inc. (MEDNAX) is a provider of physician services, including newborn, maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units, primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals, 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists and pediatric surgeons.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.